Quest PharmaTech Inc. (CVE:QPT – Get Free Report)’s share price hit a new 52-week low during trading on Tuesday . The stock traded as low as C$0.02 and last traded at C$0.02, with a volume of 790000 shares trading hands. The stock had previously closed at C$0.03.
Quest PharmaTech Stock Performance
The company has a current ratio of 0.54, a quick ratio of 0.52 and a debt-to-equity ratio of 4.49. The company has a market cap of C$2.54 million, a price-to-earnings ratio of -1.50 and a beta of 0.10. The stock has a 50 day moving average price of C$0.03 and a two-hundred day moving average price of C$0.03.
Quest PharmaTech (CVE:QPT – Get Free Report) last issued its earnings results on Friday, June 28th. The company reported C($0.01) earnings per share (EPS) for the quarter.
About Quest PharmaTech
Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer.
See Also
- Five stocks we like better than Quest PharmaTech
- How to buy stock: A step-by-step guide for beginners
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- What is the Dow Jones Industrial Average (DJIA)?
- Lowe’s Stock: Hold Now, Buy it When it Dips
- Manufacturing Stocks Investing
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Quest PharmaTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest PharmaTech and related companies with MarketBeat.com's FREE daily email newsletter.
